Cochlear Limited Stock Shares Outstanding
| CHEOF Stock | USD 208.00 7.96 3.69% |
Cochlear Limited fundamentals help investors to digest information that contributes to Cochlear's financial success or failures. It also enables traders to predict the movement of Cochlear Pink Sheet. The fundamental analysis module provides a way to measure Cochlear's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cochlear pink sheet.
Cochlear |
Cochlear Limited Company Shares Outstanding Analysis
Cochlear's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Cochlear Shares Outstanding | 65.78 M |
Most of Cochlear's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cochlear Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Cochlear Limited has 65.78 M of shares currently outstending. This is 63.56% lower than that of the Healthcare sector and 62.4% lower than that of the Medical Devices industry. The shares outstanding for all United States stocks is 88.5% higher than that of the company.
Cochlear Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cochlear's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Cochlear could also be used in its relative valuation, which is a method of valuing Cochlear by comparing valuation metrics of similar companies.Cochlear is currently under evaluation in shares outstanding category among related companies.
Cochlear Fundamentals
| Return On Equity | 0.17 | |||
| Return On Asset | 0.0973 | |||
| Profit Margin | 0.18 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 9.05 B | |||
| Shares Outstanding | 65.78 M | |||
| Shares Owned By Insiders | 0.49 % | |||
| Shares Owned By Institutions | 44.82 % | |||
| Price To Earning | 42.16 X | |||
| Price To Book | 8.08 X | |||
| Price To Sales | 5.69 X | |||
| Revenue | 1.65 B | |||
| Gross Profit | 1.24 B | |||
| EBITDA | 475.4 M | |||
| Net Income | 289.1 M | |||
| Cash And Equivalents | 629.3 M | |||
| Cash Per Share | 9.57 X | |||
| Total Debt | 253.9 M | |||
| Debt To Equity | 0.15 % | |||
| Current Ratio | 2.52 X | |||
| Book Value Per Share | 25.63 X | |||
| Cash Flow From Operations | 376.5 M | |||
| Earnings Per Share | 3.05 X | |||
| Number Of Employees | 4.5 K | |||
| Beta | 0.43 | |||
| Market Capitalization | 9.77 B | |||
| Total Asset | 2.47 B | |||
| Retained Earnings | 304 M | |||
| Working Capital | 292 M | |||
| Current Asset | 543 M | |||
| Current Liabilities | 251 M | |||
| Z Score | 22.8 | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 2.47 B | |||
| Last Dividend Paid | 3.0 |
About Cochlear Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cochlear Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cochlear using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cochlear Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Cochlear in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Cochlear's short interest history, or implied volatility extrapolated from Cochlear options trading.
Pair Trading with Cochlear
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cochlear position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cochlear will appreciate offsetting losses from the drop in the long position's value.Moving together with Cochlear Pink Sheet
| 0.73 | SYK | Stryker Financial Report 6th of May 2024 | PairCorr |
| 0.7 | SEMHF | Siemens Healthineers Earnings Call This Week | PairCorr |
Moving against Cochlear Pink Sheet
| 0.71 | AMKBY | AP Moeller Maersk | PairCorr |
The ability to find closely correlated positions to Cochlear could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cochlear when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cochlear - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cochlear Limited to buy it.
The correlation of Cochlear is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cochlear moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cochlear Limited moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cochlear can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cochlear Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Complementary Tools for Cochlear Pink Sheet analysis
When running Cochlear's price analysis, check to measure Cochlear's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cochlear is operating at the current time. Most of Cochlear's value examination focuses on studying past and present price action to predict the probability of Cochlear's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cochlear's price. Additionally, you may evaluate how the addition of Cochlear to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |